Best deals to access real time data! |
|
Real-Time Alerts for Volume Breakouts, Highs and Lows for OTC Markets and OTCBB
Monthly Subscription
for only
|
|
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
|
|
North American Extreme
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type | ISIN | Company Description |
|---|---|---|---|---|---|
| Protext Mobility, Inc. (PL) | TXTM | Other OTC | Common Stock | Common Stock |
| Price Change | Change Percent | Stock Price | High Price | Low Price | Open Price | Close Price | Last Traded  |
|
|---|---|---|---|---|---|---|---|---|
| -0.0001 | -14.29% | 0.0006 | 0.0008 | 0.000591 | 0.0007 | 0.0007 | 14:59:56 |
| Bid Price | Ask Price | Spread | Spread % | News | |
|---|---|---|---|---|---|
| 0.0006 | 0.0007 | 0.0001 | 14.29% | - | - |
| Stock Trades | Traded Volume | VWAP | Dollar Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 59 | 67,780,918 | $ 0.0006 | $ 42.09k | 37.67M | 0.0000 - 0.0056 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 14:59:57 | 10,000 | $0.00 | USD |
Protext Mobility, Inc. (PL) Financials
| Market Cap | Shares in Issue | Profit/Loss | Earnings Per Share (EPS) | PE Ratio | Float |
|---|---|---|---|---|---|
| $ 2.06M | 3.43B | $ -1.45M | - | -1.42 | 1.72B |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | 0.00% | - | - |
Protext Mobility, Inc. (PL) News
| Date | Time | Source | News Article |
|---|---|---|---|
| 9/20/2017 | 08:06 | New Media Wire | Protext Pharma Announces South Africa's Reclassification of.. |
| 8/30/2017 | 21:29 | InvestorsHub NewsWire | MJAC 2017 Speaker Update - How venture capital and.. |
| 8/28/2017 | 09:43 | InvestorsHub NewsWire | PotNetwork Holdings, Inc Confirmed for MJAC 2017 |
| 8/24/2017 | 07:40 | InvestorsHub NewsWire | MJAC 2017 International Cannabis Conference - Discount Code |
| 8/22/2017 | 00:27 | InvestorsHub NewsWire | MJAC 2017 - Speaker Update - Investing In The U.S. Cannabis.. |
| 5/23/2017 | 09:04 | InvestorsHub NewsWire | Protext Mobility Completes Name Change to Protext Pharma and.. |
| 5/04/2017 | 07:56 | InvestorsHub NewsWire | Protext Mobility Signs Agreement With Leading Research.. |
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical TXTM Price Data
| Period † | Open | High | Low | VWAP | Min Vol | Max Vol | Avg. Daily Vol [m] | Change | % |
|---|---|---|---|---|---|---|---|---|---|
| 1 Week | 0.0009 | 0.0009 | 0.0005 | 0.0007 | 33M | 126M | 75M | -0.0003 | -33.33% |
| 1 Month | 0.0006 | 0.001 | 0.000493 | 0.0007 | 1M | 193M | 52M | 0 | - |
| 3 Months | 0.0008 | 0.0012 | 0.0004 | 0.0008 | 1M | 193M | 39M | -0.0002 | -25.00% |
| 6 Months | 0.0015 | 0.0034 | 0.0004 | 0.0011 | 1M | 553M | 54M | -0.0009 | -60.00% |
| 1 Year | 0.0001 | 0.0056 | 0.000001 | 0.0012 | 0 | 598M | 80M | 0.0005 | 500.00% |
| 3 Years | 0.0004 | 0.0056 | 0.000001 | 0.0011 | 0 | 598M | 31M | 0.0002 | 50.00% |
| 5 Years | 0.014 | 0.3 | 0.000001 | 0.0010 | 0 | 598M | 24M | -0.0134 | -95.71% |
Protext Mobility, Inc. (PL) Description
| Protext Mobility, operates two wholly owned subsidiaries; Plandai Biotechnology South Africa (PTY) LTD. and Cannabis Biosciences, Inc. The Company is engaged in the research and clinical testing of bioceutical products, all natural ingredients formulated for pharmaceutical applications and processed under pharma-grade conditions. Plandai Biotechnology SA, has the exclusive worldwide license to develop pharmaceutical applications and products using the Phytofare catechin complex, which was developed by Plandai Biotechnology, Inc. Phytofare is a highly bioavailable extract produced from live green tea leaves. Our initial product, Phytofare Catechin Complex, has been clinically shown to have 10 times greater bioavailability over generic catechin extracts. Cannabis Biosciences is actively pursuing government licenses and permits that will allow it to use its proprietary processing and extraction technology to commence investigations and produce a full-profile cannabis extract, one that contains both CBD and the precursor acid form of THC (THC-A and THC-B) found in live cannabis plant. The Company's investigations will be designed to show that the Cannabis Biosciences extraction process, which will use live leaf and low temperatures to extract the phyto-chemicals, should leave the acid forms of THC intact, resulting in a non-psychoactive extract with full medicinal potential and having the heightened bioavailability of other Phytofare extracts. |
